HIV preferentially infects HIV-specific CD4+ T cells |
| |
Authors: | Douek Daniel C Brenchley Jason M Betts Michael R Ambrozak David R Hill Brenna J Okamoto Yukari Casazza Joseph P Kuruppu Janaki Kunstman Kevin Wolinsky Steven Grossman Zvi Dybul Mark Oxenius Annette Price David A Connors Mark Koup Richard A |
| |
Affiliation: | Vaccine Research Center, NIAID, NIH, Maryland 20892, USA. ddouek@mail.nih.gov |
| |
Abstract: | HIV infection is associated with the progressive loss of CD4(+) T cells through their destruction or decreased production. A central, yet unresolved issue of HIV disease is the mechanism for this loss, and in particular whether HIV-specific CD4(+) T cells are preferentially affected. Here we show that HIV-specific memory CD4(+) T cells in infected individuals contain more HIV viral DNA than other memory CD4(+) T cells, at all stages of HIV disease. Additionally, following viral rebound during interruption of antiretroviral therapy, the frequency of HIV viral DNA in the HIV-specific pool of memory CD4(+) T cells increases to a greater extent than in memory CD4(+) T cells of other specificities. These findings show that HIV-specific CD4(+) T cells are preferentially infected by HIV in vivo. This provides a potential mechanism to explain the loss of HIV-specific CD4(+) T-cell responses, and consequently the loss of immunological control of HIV replication. Furthermore, the phenomenon of HIV specifically infecting the very cells that respond to it adds a cautionary note to the practice of structured therapy interruption. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|